Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: A multicentre study

Andrea De Luca, Francesco Baldini, Antonella Cingolani, Simona Di Giambenedetto, Mauro Zaccarelli, Valerio Tozzi, Adriana Ammassari, Rita Murri, Andrea Antinori

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1655-1656
Number of pages2
JournalAIDS (London, England)
Volume14
Issue number11
DOIs
Publication statusPublished - 2000

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this